Iovance Biotherapeutics, Inc.

Snapshot as of Oct 16, 2026 close

① Price & Moving Averages

The moving-average stack SMA5 ($14.32) > SMA20 ($13.05) > SMA60 ($9.22) has held since August 7 and all three averages are still rising, but Friday's close at $13.62 slipped under SMA5, so the full Close > SMA5 > SMA20 > SMA60 order is broken at its top step. The 90-day chart is a staircase — the August 6 gap, a September climb from the $8.14 swing low (Sep 10), and the September 29 gap (about +31.5% on a company guidance update) that set the $15.30 high and a $14.82 close on September 30. Since then price has moved sideways below that September 30 close. Friday's close sits below the 23.6% retracement of that swing ($13.24) and about 4% above the rising SMA20; the 38.2% level ($12.27) lies inside the unfilled September 29 gap ($11.17–$12.78). The short-term anchored VWAP from the gap day ($14.10) is now overhead.

② Volume

The advance is defined by two volume spikes — the August 6 and September 29 gap days — and neither falls in the latest five sessions. This week was quiet: every session traded below its 20-day average, and Friday's −7.47% decline printed 12,168,100 shares, 0.696x the average of 17,479,515. The whole market was light (the median stock in our scan universe traded around 0.87x its own average that day), so the drop does not look like heavy liquidation. Equally, the October 9 and October 15 up days were not accompanied by expanding volume. Volume has simply contracted since the gap, which fits a digestion phase more than a fresh push.

③ MACD

MACD (1.300) crossed below its signal line (1.410) on October 14, ending the run that began with the September 16 golden cross; the histogram is now −0.110 and widened on Friday. The cross happened far above zero, so it reads as momentum cooling inside an uptrend rather than a trend reversal — the MACD line itself is still strongly positive. A dead cross this high often resolves into a sideways pause; the histogram turning back toward zero would be the first sign the pause is ending, while a MACD line falling toward the zero axis would mean the trend itself is weakening.

④ RSI

RSI(14) dropped to 59.88 on Friday, out of the overbought zone it had occupied for most of the past two weeks. The chart tool flags a bearish RSI divergence: its first reference peak is August 20 (price $8.99, RSI 83.51), and the second price reference is the October 15 close of $14.72 — a much higher price with lower momentum readings in October. (The RSI figure attached to that second peak in the data does not match the same-day RSI reading, so it is not quoted here.) A divergence is a caution flag, not a top call; it gained some weight this week because price did follow through lower. RSI holding the 50 area on further weakness would keep the trend's momentum profile intact.

⑤ Mansfield Relative Strength

Relative strength is why IOVA was selected: Mansfield RS vs the Nasdaq Composite is +180.15, deep in outperform territory. Week over week it fell 21.21 points (from +201.35) — still positive, but slowing — while month over month it is up 31.24 points (from +148.91), still accelerating on the longer view. The RS line was above zero and climbing through August and September before the gap; the past two weeks have given back part of the gap-day step. A third consecutive weekly decline would be a clearer sign that leadership against the Nasdaq Composite is fading.

⑥ ATR · ADX

ADX at 54.62 still marks a strong trend, though it has been edging down since early October as price moved sideways. ATR is $0.87, or 6.40% of price — near the top of its 90-day range after the gap and the wide October sessions. The 1× ATR reference is $12.75 and the 2× ATR reference is $11.88, about 12.8% below the close and inside the September 29 gap. With daily ranges this wide, position size matters more than the exact level.

⑦ OBV

OBV has shifted to early distribution on both timeframes: below its MA20 with a flat slope on the 2-year view (MA20 gap −7.28%) and on the 90-day view (−2.37%). On the 90-day chart OBV peaked with the September 29–30 surge, drifted lower through October and has now dipped just under its rising MA20 after Friday's decline. No OBV divergence is flagged. This is a mild warning rather than a heavy one — the volume behind recent down days was light — but it means volume flow is no longer confirming the trend the way it did through September.

Bull vs Bear

Scenarios

Key Levels

What to Watch

• Whether closes hold above the rising SMA20 ($13.05) and the Sep 29 gap top ($12.78).
• The MACD histogram — narrowing back toward zero would suggest the Oct 14 dead cross is a pause, not a turn.
• OBV recovering above its MA20 on the 90-day view versus extending lower.
• Mansfield RS week over week — a third consecutive drop would mean the leadership is cooling against the Nasdaq Composite.
• A close back above the 90d aVWAP ($14.10) on rising volume.

Conclusion

Past Analyses of This Stock same ticker · newest first

Other signals from this issue same publication date · 6 stocks

← Back to all analyses